Clinical Trial Update: Nalbuphine for the Treatment of Opioid Induced Pruritus in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating nalbuphine for opioid-induced pruritus in children has completed, as noted in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Drugs mentioned

• Nalbuphine (nalbuphine)

Snippet

Sponsor: University of British Columbia | Conditions: Pruritis | Phase 3 | Status: COMPLETED